A phase III trial of SB-204 in patients with acne vulgaris

Trial Profile

A phase III trial of SB-204 in patients with acne vulgaris

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Acne vulgaris
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 13 Nov 2017 New trial record
    • 07 Nov 2017 According to a Novan Inc. media release, this pivotal trial is required before the filing of a New Drug Application for SB-204 in the treatment of acne vulgaris.
    • 07 Nov 2017 According to a Novan Inc. media release, the company anticipated to finalize the clinical trial execution after joint discussion of the trial protocol with the US FDA in the first quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top